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Networks of signaling molecules are activated in response to environmental changes. How
are these signaling networks dynamically integrated in space and time to process partic-
ular information? To tackle this issue, biosensors of single signaling pathways have been
engineered. Bioluminescence resonance energy transfer (BRET)-based biosensors have
proven to be particularly efficient in that matter due to the high sensitivity of this tech-
nology to monitor protein–protein interactions or conformational changes in living cells.
Extracellular signal-regulated kinases (ERK) are ubiquitously expressed and involved in
many diverse cellular functions that might be encoded by the strength and spatio-temporal
pattern of ERK activation. We developed a BRET-based sensor of ERK activity, called Rluc8-
ERKsubstrate-Venus (REV). As expected, BRET changes of REV were correlated with ERK
phosphorylation, which is required for its kinase activity. In neurons, the nature of the
stimuli determines the strength, the location, or the moment of ERK activation, thus high-
lighting how acute modulation of ERK may encode the nature of initial stimulus to specify
the consequences of this activation. This study provides evidence for suitability of REV as
a new biosensor to address biological questions.
Keywords: biosensor, bioluminescence resonance energy transfer, BRET imaging, fluorescence lifetime imaging
microscopy, extracellular signal-regulated kinases, spatio-temporal signaling, Rluc8-ERKsubstrate-Venus
INTRODUCTION
The specificity of cellular responses to receptor stimulation is
encoded by the spatial and temporal dynamics of downstream sig-
naling networks. Cells indeed respond to multiple external stimuli
thanks to a surprisingly limited number of signaling pathways
activated by plasma membrane receptors. To encode and make
distinct various external signals these commune pathways have
to be precisely regulated in space and time. Thus distinct spatio-
temporal activation profiles of a shared repertoire of signaling
proteins result in different gene activation patterns and diverse
physiological responses (1–3).
An emerging picture of interrelated networks has therefore
superseded the former preconceived scheme of discrete linear
pathways to convey extracellular signals to specific targets. In fact,
various receptor pathways share a common protein catalog that
mediates signal transduction. For any individual receptor path-
way, there is no single protein or gene responsible for signaling
specificity. Rather, specificity is determined by the temporal and
spatial dynamics activation of downstream signaling components.
To address and answer the questions surrounding the specificity
of signal to response events, signaling reporters for individual
downstream signaling components activation in intact cellular
environment will be required.
In recent years, efforts have been made to study the dynamic cel-
lular processes by the engineering of biosensors specific to various
signaling pathways. Resonance Energy Transfer technologies (Flu-
orescent, FRET or Bioluminescence resonance energy transfer,
BRET) have proven to be efficient in this area by enabling the mon-
itoring of protein–protein interactions or protein-conformational
changes in living cells. FRET and BRET technologies are both
based on the non-radiative transfer of energy between the donor
and acceptor molecules via the Förster mechanism and pri-
marily depend on: (1) an overlap between the emission and
excitation spectra of the donor and acceptor molecules, respec-
tively; and (2) the close proximity of the donor and acceptor
entities (<100 Å) (4, 5). In the case of FRET, both the donor
and acceptor are fluorescent molecules, whereas in BRET, the
energy donor is a bioluminescent molecule. FRET necessarily
requires fluorescence excitation, resulting in problems of pho-
tobleaching, autofluorescence, simultaneous excitation of both
donor and acceptor fluorophores, phototoxicity, and undesir-
able stimulation of photobiological processes. Most of these
FRET drawbacks tend to be corrected with the emergence
of technologies like TR-FRET or Fluorescence Lifetime Imag-
ing Microscopy (FLIM) (6, 7). Nevertheless, the use of BRET
allows these practical problems to be bypassed, as it is initiated
by an enzymatic reaction (instead of fluorescence excitation).
Accordingly, bioluminescence-initiated resonance energy trans-
fer results in greater sensitivity in living subjects because of a
higher signal to background ratio, and therefore makes BRET a
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technology of choice for measurements from cell lysates or intact
cells (8).
The Mitogen-Activated Protein Kinases (MAPK) family is
a class of serine/threonine kinases [including the Extracellular
signal-regulated kinases (ERK), p38, and JNK sub-families] that
are ubiquitously expressed, activated by various stimuli and there-
fore involved in numerous cellular functions. The ERK signaling
cascade is a central MAPK pathway that plays a role in the reg-
ulation of various cellular processes such as proliferation and
differentiation, development, neuronal plasticity and learning,
survival, and apoptosis (9, 10). The ability of this cascade to reg-
ulate so many distinct and even opposing cellular processes raises
the question of signaling specificity determination by this cas-
cade. Duration and strength of the signals, interaction with specific
scaffolds, changes in sub-cellular localization, crosstalk with other
signaling pathways, and presence of multiple components with
distinct functions in each tier of the cascade seems to determine
the ultimate function of ERK activation (11–14). The reliability of
signaling and the spatio-temporal activation of ERK are therefore
key context-dependent determinants that need to be deciphered
in order to resolve the nature of precise biological responses.
To better understand the final outcome of intricate factors con-
trolling the kinetics of ERK activity, signaling reporters in living
cells have been engineered (15–18). In the present work we used
the most efficient biosensor for ERK activity so far tested (18).
We reproduced published data, however the sensitivity of this
FRET biosensor was not sufficient to detect subtle variations of
ERK activity in neurons. We therefore improved this biosensor by
switching the FRET tags to BRET compatible entities. We then
defined the proper experimental conditions to record accurate
BRET signals with this ERK-biosensor, described the potential
and limitation of this upgraded reporter, and discussed possible
further improvements. This work also addresses general technical
concerns about the use of biosensors.
MATERIALS AND METHODS
REAGENTS
Glycine (200µM), strychnine (1µM), GABA (100µM), U0126
(10µM), PMA (1µM), and KCl (50 mM) were all purchased from
Sigma-Aldrich, St Quentin Fallavier, France. NMDA (50µM) was
purchased from Tocris (Fisher-Bioblock, Illkirch, France) and epi-
dermal growth factor (EGF) (50 ng/ml) from Calbiochem (Merck-
Millipore, Darmstadt, Allemagne). We used the following primary
antibodies: p44-42 MAP Kinase Antibody (Cell Signaling Tech-
nology, #9102), phospho-p44p42 MAP Kinase (Thr202/Tyr204)
antibody (Cell Signaling Technology, #9101), p-Thr-48-Cdc25C
antibody (Cell Signaling Technology, #9527), and rabbit GFP
antibody (Invitrogen, A11122).
REV CONSTRUCTION
Plasmids coding for nuclear and cytoplasmic Extracellu-
lar signal-regulated Kinase Activity Reporter (EKAR), pRK5-
Cerulean-EKARNucl-Venus, and pRK5-Cerulean-EKARcyto-Venus
(18) (Addgene, Cambridge, MA, USA) were digested by ClaI
and BamHI restriction enzymes to remove the Cerulean-coding
sequence and replace it by the Rluc8-coding sequence ampli-
fied by PCR between ClaI and BamHI restriction sites. We thus
obtained two plasmids: pRK5-Rluc8-EKARNucl-Venus and pRK5-
Rluc8-EKARcyto-Venus. Inactive mutants were made by mutation
in EKAR Cdc25C peptide “PDVPRTPVGK” (Thr-to-Ala sub-
stitution). The control pRK5-Rluc8-EKAR (cyto) plasmid was
designed from the pRK5-Rluc8-EKARcyto-Venus construct: the
original Rluc8-ERKsubstrate-Venus (REV) sequence was removed
by a ClaI/BrsGI enzymatic digestion and replaced with a Rluc8-
EKAR sequence obtained by PCR on pRK5-Rluc8-EKARcyto-
Venus with insertion of ClaI/BrsGI appropriate restriction sites.
CELL CULTURES AND TRANSFECTION
HEK293T cell culture and calcium phosphate transfection were
performed as previously described (19). To determine the optimal
level of REV expression we performed many transfections with
different amounts of pRK5-Rluc8-EKARNucl-Venus and pRK5-
Rluc8-EKARcyto-Venus plasmids, ranging from 0.1 ng to 4µg of
each plasmid per 100 mm diameter cell dish (3,000,000 cells). The
total amount of DNA per plate dish was complemented with the
non-coding plasmid pcDNA3 to reach 5µg of DNA in each trans-
fection. We chose the transfection condition containing 20 ng of
REV-coding plasmids for the other experiments. Hippocampal
neuronal primary cultures were prepared from 17.5 days embry-
onic mice (E17.5) and grown in neurobasal medium (Gibco,
Invitrogen, Cergy Pontoise, France) supplemented with 2% B-27
(Gibco), glutamax (4 mM, Gibco), glutamic acid (25µM, Gibco),
antibiotics (Penicillin 100 U/ml and Streptomycin 100µg/ml), and
10% Fetal Bovine Serum (FBS), in 35 mm diameter glass bot-
tom culture dishes (MatTek Corporation, Ashland, MA, USA).
After 3 days in culture (DIV3), the culture medium was sup-
plemented with Cytosine β-d-arabinofuranoside hydrochloride
5µM (Sigma-Aldrich, St Quentin Fallavier, France) for 12 h. Then,
75% of the medium was replaced by neurobasal medium sup-
plemented with B-27, glutamax, and antibiotics. Neurons were
then transfected with 100 ng of pRK5-Rluc8-EKARNucl-Venus and
pRK5-Rluc8-EKARcyto-Venus plasmids and 1.8µg of the non-
coding plasmid pcDNA3 using Lipofectamine 2000 (Invitrogen,
Cergy Pontoise, France) according to the manufacturer’s standard
protocol at DIV10 and studied between DIV11 and DIV12.
IMMUNOFLUORESCENCE STAINING AND IMAGING
Immunofluorescence staining was performed on HEK cells, trans-
fected or not with REV, were fixed with 4% PFA for 10 min at room
temperature, permeabilized with Triton X-100 0.15% for 10 min,
washed and incubated with blocking buffer (FBS 10%, BSA 1%
in PBS) for 2 h at RT. Polyclonal antibodies raised against p44-42
MAP kinase were incubated overnight at 4°C in PBS containing 1%
BSA. After three rinses with PBS, the anti-mouse Cy3-conjugated
antibodies (1:500, Jackson) were added for 30 min at RT. Three
rinses with PBS were carried out before mounting cells directly in
the wells under cover slips.
Images were obtained with LSCM (OLYMPUS, FV-1000, 60×
objective), equipped with appropriate epifluorescence and filters
(Green: 475_40 and 530_50 nm for excitation and emission respec-
tively, Red: 545_25 and 605_70 nm for excitation and emission
respectively). Images were digitized and saved in TIFF format
using the Andor software and further analyzed using the ImageJ
software (NIH).
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WESTERN BLOTS
Cells were lysed in 0.1% Triton X-100, 150 mM NaCl, 2 mM
EGTA, anti-protease mixture (Roche Applied Science), phos-
phatase inhibitors (Na3VO4, NaP2O3, NaF), and 20 mM Tris-HCl,
pH 7.4 (lysis buffer), and the mixture was centrifuged. The super-
natant was incubated in a Laemmli buffer at 90°C. Proteins were
transferred to nitrocellulose (NC) membranes (Millipore, Bed-
ford, MA, USA) and blocked in blocking buffer (5% non-fat dry
milk in TBS and 0.1% Tween 20) for 1 h. The blots were then
incubated with primary antibodies at the relevant dilution (Cell
Signaling Technology, Beverly, MA, USA) for 1 h at room tempera-
ture, and with horseradish peroxidase-linked secondary antibodies
(1:20,000; Pierce, USA) for 2 h. Immunoblots were revealed using
the enhanced chemiluminescence reagents (Thermo, USA) and
visualized using the X-ray film. The density of immunoreactive
bands was measured using NIH image software, and all bands
were normalized to percentages of control values.
FLUORESCENCE LIFETIME IMAGING MICROSCOPY
Time-domain FLIM was performed with a multiphoton
microscopy system, based on a Zeiss Axiovert 200M LSM 510 Meta
NLO equipped with a Ti:Sapphire Chameleon-XR pulsed laser
(Coherent). Time-resolved detection was afforded by the addition
at a non-descanned output of a fast photomultiplier and SPC-
830 time-correlated single-photon counting (TCSPC) electronics
(7). For EGFP excitation, laser power at 900 nm was adjusted to
give average photon counting rates of the order 104–105 photons
s−1 (0.0001–0.001 photons/excitation event) and with peak rates
approaching 106 photons s−1, below the maximum counting rate
afforded by the TCSPC electronics to avoid pulse pile-up. Acquisi-
tion times of 120 s were used. Analysis of the fluorescent transients
was performed with the SPCImage software package (7). Images
were taken with a Zeiss 63×/1.0 W Plan-Apochromat objective.
BRET MEASUREMENTS
Bioluminescence resonance energy transfer measurements in cell
populations were performed as previously described (19). Single
cell BRET imaging in cultured hippocampal neurons to study the
sub-cellular localization of REV-conformational changes were per-
formed according to previous protocols (20, 21). Briefly, images
were obtained using a Plan-Apochromat 63×/1.40 Oil M27 objec-
tive, at room temperature. Hippocampal neurons were transfected
at DIV10 and recorded at DIV11 or DIV12 in the following exter-
nal medium (in millimolar): 140 NaCl, 0.5 CaCl2, 3 KCl, 10
HEPES, 10 d-Glucose, 0.0003 tetrodotoxin, pH 7.4 and osmo-
larity of 330 mOsm. Transfected cells were first identified using a
monochromatic light and appropriate filter to excite Venus (exciter
HQ480/40 #44001 – emitter HQ600/50 #42017, Chroma). The
light source was then switched off until the end of the experiment.
Coelenterazine H (CoelH, 20µM) was applied for 5 min before
acquisition with Metamorph software (Molecular Devices). BRET
images were collected every 30 s by sequential acquisitions from
the 535 and 480 nm channels of 7 s each, using the evolve cam-
era from Photometrics. Drugs were added 2 min (or four images)
after the first acquisition. Sequential acquisitions were performed
at 5 MHz (Gain 3950, binning 1) with emission filters D480/60 nm
(#61274, Chroma) and HQ535/50 nm (#63944, Chroma) to select
em480 and em535 wavelengths respectively. We applied an exclu-
sive threshold on the em480 image, from 0 to 4,000 counts, in
order to exclude these non-reliable weak values (see Figure 3A).
The pixel-by-pixel 535/480 nm ratios were calculated by divid-
ing the absolute blue or yellow intensities per pixel of images
obtained at 535 nm over 480 nm. These numerical ratios (com-
prised between 0 and 1.5) were translated and visualized with a
continuous 256 pseudo-color look-up table (LUT) as displayed in
the figures. We determined the average intensity (“mean”) and dis-
tribution (“Standard Deviation”) of the 535/480 nm fluorescence
ratios, in a square region of pixels drawn on the sub-cellular com-
partment of interest using Image J software (NIH). The “mean”
measured the global BRET intensity in that area, while the “Stan-
dard deviation” of BRET from pixel to pixel gave information
about the distribution of the BRET signals in that area. These are
two complementary pieces of information. We then averaged the
mean± SEM and Standard Deviation± SEM obtained from three
to six cells and seven square regions per cell in the same sub-cellular
compartment and in identical stimulating conditions. Please note
that a high standard deviation indicates a spatial clusterization of
the BRET signals and not a variation of mean between similar
areas, this latter being detected by the “SEM” of the mean.
STATISTICAL ANALYSES
Analyses were performed using Prism software. Statistical analyses
were performed with the non-parametric Kruskal and Wallis test
for more than two independent samples or with Friedman test for
paired samples with a “p” risk threshold of 5%.
RESULTS
CONSTRUCTION OF “REV,” A BRET-BASED SENSOR OF ERK ACTIVITY
Extracellular signal-regulated Kinase Activity Reporter is a FRET-
based sensor of ERK activity optimized for signal-to-noise ratio
and FLIM (18). Briefly, the ERK activity sensor includes a substrate
phosphorylation peptide from Cdc25C containing the consensus
MAPK target sequence (PRTP) (22), and the proline-directed WW
phospho-binding domain (23) boxed between FRET compatible
entities (EGFP and mRFP1). Phosphorylation of the substrate
sequence by ERK activation induces the binding of the phospho-
binding domain and subsequent conformational rearrangement,
thus triggering a change in FRET between the donor and accep-
tor entities. Because specificity in MAPK signaling depends on
docking domains (24), EKAR contains an ERK specific docking
site (FQFP) next to the phosphorylation sequence (25). Finally, a
central flexible linker consisting of 72 glycine residues spaces out
the phospho-binding domain from the substrate peptide to allow
conformational changes (18).
Extracellular signal-regulated Kinase Activity Reporter selec-
tively and reversibly reported ERK activation in HEK293T cells
after EGF stimulation (18). Using FLIM, we corroborated these
data (Figure A1 in Appendix). However in our hands, this FRET-
based sensor failed to report weaker biological stimuli also thought
to modulate ERK activity. In order to detect subtle modula-
tions of ERK activity with this biosensor, we hypothesized that
the sensitivity of the assay would be improved by replacing the
FRET donor and acceptor pair by BRET compatible entities. We
therefore engineered a construct in which the Renilla Luciferase
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(Rluc8) and acceptor Yellow Fluorescent protein Venus are box-
ing the ERK substrate (Figure 1A), so-called “REV.” Because
of the nuclear localization of the WW domain, REV expres-
sion was restricted to the nucleus when expressed in HEK293T
cell (REVnucl, Figure 1B). We engineered a second plasmid con-
taining an additional DNA sequence coding for a C-terminal
nuclear export sequence, which resulted in cytoplasmic expres-
sion (REVcyto, Figure 1B). We controlled that REV transfection
in HEK cells did not impair endogenous ERK expression. Both of
them were broadly expressed in the cell (Figure A1B in Appendix).
To characterize REV as a new ERK-biosensor, HEK293T cells were
transfected with both nuclear and cytosolic plasmids, except when
specified.
DEFINING THE EXPERIMENTAL CONDITIONS TO DEPICT RELIABLE
BRET SIGNALS TO REPORT ERK ACTIVITY
Rluc8-ERKsubstrate-Venus being an intra-molecular BRET
biosensor, the stoichiometry of donor and acceptor entities is
constant: one Rluc8 for one Venus per molecule. In its non-
phosphorylated form, the reporter adopts an “open” confor-
mation. Upon phosphorylation, conformational bending of the
biosensor increases the proximity between the donor and accep-
tor in a “closed” conformation and induces a BRET-increase to
report its phosphorylation by ERK. In an attempt to properly
define the experimental conditions allowing reliable BRET sig-
nals, we first assessed the optimal expression level of REV. Three
main criteria have to be fulfilled. This optimal expression must
indeed be sufficient to be within the linear range of detection
of the luminescence and fluorescence signals of the donor and
acceptor entities respectively. However, too high a level of REV
expression could induce non-specific inter-molecular BRET due
to random collisions between proteins, which would bias the
analysis. Finally, a minimal expression of REV would maximize
its phosphorylation by endogenous kinases activation, while an
excess of REV expression would preclude the phosphorylation of
all molecules by ERK and thus prevent adequate detection of ERK
activity. We thus performed several transfections of HEK293T cells
with increasing quantity of REV expression plasmids (see Mate-
rials and Methods). The BRET signal expressed as a function of
the fluorescence (which is proportional to the REV expression
level) was constant, except for weak expression of REV revealing
the limit of detection of the luminescent and fluorescent signals
FIGURE 1 | Design and characterization of REV, a BRET-based sensor of
ERK activity. (A) Schematic representation of ERK sensor-conformational
changes induced upon ERK activation, adapted from Harvey et al. (18). The
conformational change induced by REV-phosphorylation increases the
proximity between Rluc8 and Venus, promoting BRET-increase. (B)
Fluorescence of REVnucl and REVcyto transfected alone or together in HEK293T
cells. (C) Determination of the expression level of REV required for a reliable
BRET measurement. HEK293T cells were transfected with increasing
amounts of pRK5-Rluc8-EKARNucl-Venus and pRK5-Rluc8-EKARcyto-Venus
plasmids. BRET in cell population was expressed as a function of
REV-fluorescence reporting the expression level of REV. Note that the BRET
remained constant for a fluorescence of REV comprised between 200 and
1,300 photon counts which corresponds to cells transfected with 10–4,000 ng
of plasmid per 100 mm diameter culture dish. (D) Determination of the
expression level of REV required for efficient report of ERK activation.
HEK293T cells transfected with increasing amounts of pRK5-Rluc8-EKARNucl-
Venus and pRK5-Rluc8-EKARcyto-Venus plasmids were stimulated with EGF
and recorded over time. Note that EGF-induced ERK activity could be reported
only in cells transfected with 10–100 ng of plasmid per 3,000,000 cells. (E)
Basal BRET measured in HEK293T cells transfected with REV or REVT/A
inactive mutants. Each bar of the histogram represents the mean±SEM of
five independent experiments performed in triplicate. Note that the
unphosphorylated form of REV, REVT/A, displays a lower BRET signal than the
wild-type REV, highlighting a basal activity of ERK in our experimental
conditions. The non-null net BRET of REVT/A also emphasizes a basal BRET in
the unphosphorylated (open) conformation of REV. (C–E) BRET in cell
population were measured in the Mithras luminescence-fluorescence plate
reader. Net BRET values were calculated by subtraction of the BRET obtained
in cells transfected with Rluc8 alone, and multiplied by 1,000 to be expressed
as milli BRET unit (mBu).
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(Figure 1C). No inter-molecular BRET interference was detected
for this range of protein expression. To assess the optimal quan-
tity of DNA coding for REV to efficiently report ERK activation,
we applied EGF on cells transfected with 0.1–4,000 ng of plasmid
DNA coding for REV (Figure 1D). EGF-induced ERK activation
was detected only in transfection conditions ranging from 10 to
100 ng of REV plasmid per 100 mm diameter cell dish (3,000,000
cells). In cases of ERK substrate (REV) stronger expression, only
a small amount of REV might be phosphorylated by ERK activa-
tion, which prevents the optimal detection of ERK activity. In the
following experiments, to favor REV-phosphorylation by endoge-
nous kinases, we thus selected the transfection condition giving
rise to the weakest expression level of REV within the linear range
of BRET (corresponding to 20 ng of DNA per 100 mm cell dish,
Figure 1C).
HEK293T cells expressing REV displayed a mean basal net
BRET signal of 255.55± 1.15 milli BRET units (mBu, Figure 1E).
This basal BRET signal might report either a sufficient prox-
imity between the donor and acceptor entities in the non-
phosphorylated conformation of REV and/or a non-null phos-
phorylation of REV due to a basal activity of ERK. To discrim-
inate between these two possibilities, we mutated the MAPK
phosphorylation site in the Cdc25C peptide (Thr-to-Ala substi-
tution, REVT/A) (18). The basal BRET displayed by the REVT/A
mutant was significantly weaker (225.64± 2.6 mBu) than the wild-
type biosensor (Figure 1E), highlighting a basal ERK activity.
This was further confirmed by perfusion of the ERK pathway
inhibitor U0126 (10µM), which induced a BRET decrease of
−32.79± 0.68 mBu in REV-transfected cells (Figure 2A). The
remaining basal BRET with REV in presence of U0126 and the
non-null BRET displayed by the REVT/A mutant both evidenced
a proximity between Rluc8 and Venus in the non-phosphorylated
form of REV compatible with intra-molecular BRET.
REV EFFICIENTLY AND SPECIFICALLY REPORTS ERK ACTIVITY IN LIVING
CELLS
To assess the efficiency of REV to report ERK activation, REV-
expressing cells were stimulated with EGF (50 ng/ml) or phorbol
myristate acetate (PMA, 1µM) to strongly activate ERK signal-
ing. EGF application induced a transient BRET-increase that was
maximal 5 min after stimulation (Figure 2A). Conversely, the
PMA-induced BRET-increase was slower (maximal 15 min after
stimulation), but stable for more than 1 h (Figure 2A). Both EGF-
and PMA-induced BRET-increases could be reversed by applica-
tion of the ERK inhibitor U0126 (10µM, dotted lines, Figure 2A).
Furthermore, no BRET changes were recorded upon PMA appli-
cation in HEK293T cells transfected with the mutant REVT/A,
confirming the specificity of the biosensor to report ERK phos-
phorylation specifically (Figure 2B). Under EGF- or PMA-induced
ERK stimulations, no difference was found between nuclear and
cytosolic REV reporters when expressed separately (Figure 2C).
These drug-specific profiles of ERK activation reported by REV
were in accordance with western blot (WB) analyses to reveal the
phosphorylated form of endogenous ERK and transfected REV
(using Anti-ERK and Anti-phospho-Thr-48-cdc25c antibodies,
respectively) (Figure 2E). However, we noticed a slight shift in
time of the maximal ERK activity using WB compared to real-time
BRET experiments. This temporal shift might be the result of the
WB experiment’s lack of precision due to the use of detergent to
lyse cells and solubilize proteins. The BRET sensor thus appeared
to be an accurate reporter of ERK activity, with the main advan-
tage of reporting the modulation of ERK activity in real time in
the same living cells.
To characterize the sensitivity of this BRET-based sensor,
we measured the ratio of EGF-induced increase in REV BRET
(57.32± 1.03 mBu, mean± SEM obtained from three individual
experiments) over the standard deviation of BRET signals in basal
condition (2.53± 0.14 mBu, mean of Standard Deviation± SEM
obtained from three individual experiments) and found that the
EGF-induced REV BRET-increase was 22.6 times higher than
the standard deviation of the BRET. Similar quantification was
performed with EKAR, the most sensitive FRET-based sensor
so far published. FLIM experiments showed an EGF-dependent
decrease in EGFP fluorescence lifetime of 0.0560± 0.0082 ns for a
0.0147± 0.0017 ns standard deviation of the signal in basal con-
dition. The EGF-induced FRET increase was therefore 3.8 times
higher than the standard deviation. To place emphasis on the
higher sensitivity of REV, we normalized EGF-induced EKAR and
REV signals modulation to the standard deviation of FRET and
BRET signals respectively (Figure 2D).
The high sensitivity of REV suggested the possibility of report-
ing subtle modulations of ERK activity with this BRET-based
sensor, which we failed to do with EKAR by FRET/FLIM. For
example, GABA-B receptor stimulation in HEK293T cells trans-
fected with GB1 and GB2 subunits induced a shorter and weaker
increase in ERK activity as shown by WB (Figure 2E). This tran-
sient weak activation of ERK activity could successfully be reported
in real time with REV in living cells (Figure 2A). Taken together,
these results identify REV as a sensitive biosensor to report ERK
activity in living cells, providing that its expression level was suf-
ficient to reliably read the BRET signals but weak enough to allow
its phosphorylation by endogenous ERK.
REV REPORTS STIMULUS-SPECIFIC RESPONSES OF ERK SIGNALING IN
NEURONAL SUB-CELLULAR COMPARTMENTS
In light of the good sensitivity of REV, we performed BRET
imaging experiments in hippocampal neurons to depict the spatio-
temporal dynamics of ERK activation. First, as mentioned previ-
ously for BRET in cell population, a sufficient level of expression is
needed in order to be in the linear range of detection of lumines-
cence and fluorescence. This consideration also applies to BRET
imaging to obtain an accurate evaluation of BRET signals. To
determine a cut-off for the minimal level of luminescence emis-
sion required for an accurate BRET ratio measurement, we mea-
sured the evolution of Em480, Em535, and BRET intensity over
time (Figure 3A). The BRET signal over time was constant until
the luminescence decreased fewer than 4,000 counts where the
fluctuation between successive BRET readings strongly increased.
Accordingly, in order to exclude these non-reliable pixels of weak
emission, we applied an exclusive threshold on the Em480 image
before carrying out the pixel-by-pixel division of Em535/Em480
to obtain the BRET image.
One of the major difficulties in establishing BRET imag-
ing is to distinguish the signal originating from the transfer of
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FIGURE 2 | REV, a sensitive BRET sensor of ERK activity. (A–D)
Drug-induced BRET changes of REV were measured in HEK293T cells
population, in the Mithras luminescence-fluorescence plate reader. Cells were
transfected with both cytosolic and nuclear constructs of REV (A,B,D) or only
one of the two constructs (C). In A, green line, GB1 and GB2 subunits of
GABA-B receptor were co-transfected with REV. (A) EGF, PMA, and GABA
application induced a BRET signal increase with different intensity and
temporal profile, while U0126 decreased the BRET. The PMA or EGF-induced
increase of BRET could be reversed by U0126 application (dotted lines, U0126
application is symbolized by the arrow, 300 s after PMA or EGF perfusion). (B)
PMA-induced BRET changes was measured in HEK293T cells transfected
with REV or REVT/A. The absence of effect of PMA in REVT/A-transfected cells
validated the specificity of REV to report ERK activation. (C) BRET changes
induced by PMA (red) or EGF (blue) were measured in the cytosol (full lines)
or nucleus (dotted lines). (D) Sensitivities of EKAR (FRET/FLIM-based
reporter) and REV (BRET-based reporter) were compared by normalizing the
EGF-effect to the standard deviation in their respective technology. (E) ERK,
phospho-ERK (p-ERK), REV (GFP), and phospho-REV (p-cdc) staining
quantified by western blot in HEK293T cells transfected (GABA – green line)
or not (EGF and PMA conditions, blue and red line) with GB1 and GB2
subunits of GABA-B receptor before and up to 60 min after drug application.
When specified, following 10 min of EGF or PMA incubation, U0126 was
added for 50 min. p-ERK/ERK ratio were calculated in each column and
normalized to the p-ERK/ERK ratio measured before stimulation (t =0). Each
point of the graph below represents the mean±SEM obtained from three
individual experiments, for each time condition.
energy from that resulting from an overflow of the energy donor
output into the energy acceptor detection channel. To control
for this basal signal, we engineered a REV construct without
Venus (RE). Neither the mean BRET signal nor the standard
deviation, were found to be significantly different in the soma
and dendritic areas (Figure 3B). As expected, RE displayed a
homogenous and weak basal BRET, independent on the lumi-
nescence level. This validated the accuracy of our experimental
conditions.
In neurons, ERK activity is modulated by the neuronal activ-
ity and has been involved in opposing cellular processes such as
long term potentiation (LTP) or depression (LTD) of the synaptic
transmission (26). Several studies have shown that ERK activity is
indeed regulated by different stimuli, among which we chose three
examples. (1) KCl depolarization induces sustained ERK activa-
tion in hippocampal neurons (27, 28). (2) Selective extrasynaptic
NMDA receptor activation (as well as NMDA bath application)
does not activate ERK pathways, whereas (3) synaptic NMDAR
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FIGURE 3 | Stimulus-specific responses of ERK signaling reported by
REV in neuronal sub-cellular compartments. (A) Evolution of Em480,
Em535, and 535/480 ratio signals over time. Sequential BRET images on
neurons expressing REV were acquired for 50 min. The red arrow indicates
the cut-off value for luminescence intensity below which BRET
fluctuations prevented adequate measurements. (B) Basal signal resulting
from the overflow of the energy donor output into the energy acceptor
detection channel. Neurons were transfected with RE (REV construct
without Venus). Left, representative BRET image. Right, BRET intensity
(mean) and distribution (Standard Deviation) in soma and dendrites. Each
bar of the histogram represents the mean±SEM obtained from three to
six neurons and seven regions per neuron. (C) ERK and phospho-ERK
(p-ERK) staining quantified by western blot in hippocampal neurons
stimulated or not (black) with NMDA (50µM, blue), Glycine and strychnine
(200 and 1µM, respectively, green), or KCl (50 mM, red) for 10 min. (D)
Real-time BRET imaging of four representative hippocampal neurons
transfected with REV, in the stimulated conditions described in (A).
Changes of average intensity and standard deviation over time were
measured on the soma and dendritic shaft of each image. (E) Intensities of
BRET signals recorded on dendrites of neurons in BRET images over time.
Each point of the graph represents the mean±SEM obtained from three
to six neurons and seven regions per neuron, for each time condition.
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activation – to induce a chemical LTP – induces ERK activation
(29). WB experiments indeed confirmed these findings but only
KCl application was found to be significantly different from the
non-stimulated condition (Figure 3C).
To further decipher stimulus-specific responses of ERK sig-
naling we used REV to report in living neurons the location,
duration, and strength of ERK activity in sub-cellular compart-
ments. Compared to control condition (buffer perfusion), KCl
application (50 mM, 10 min) induced a sustained increase in
BRET intensity both in soma and dendrites, reporting ERK activa-
tion upon depolarization (Figures 3D,E). The standard deviation
increased in dendrites, suggesting an important clusterization
of ERK activity induced by KCl application (Figure 3D). Con-
versely, NMDA bath application (50µM, 10 min) decreased the
BRET signal intensity and this inhibition of ERK activity could
be seen in dendrites only (Figure 3D). Thus, while a global
approach such as WB experiment failed to report significant
modulation of ERK activity by NMDA (Figure 3C), the possi-
ble sub-cellular analysis with the BRET-based sensor highlighted
a dendritic significant inhibition of ERK activity (Figure 3E).
In presence of glycine and strychnine (200 and 1µM, respec-
tively, for 3 min) the BRET intensity slightly increased in soma
and dendrites as well as standard deviation in dendrites, com-
pared to control condition (Figure 3D). However, in contrast
to the KCl-induced increase and NMDA-induced decrease, this
Glycine-induced modulation of BRET signals was not significantly
different from the control condition when several experiments
were pooled (Figure 3E).
DISCUSSION
In the present work we have engineered and tested the first BRET
reporter of ERK activity, REV. REV selectively and reversibly
reported ERK activity after EGF or PMA stimulation in HEK293T
cells and following changes in neuronal activity in hippocam-
pal neurons. REV therefore allows the analysis of ERK signaling
in time and space in living cells. We here defined the experi-
mental conditions required to use this BRET-based sensor and
achieved a proof of principal study to highlight several advan-
tages of REV to improve the detection of ERK activity. Finally
REV was used to point out spatio-temporal profiles of ERK
activity induced by different stimuli, so far unrevealed by other
technologies.
Our results highlight the need to carefully control the expres-
sion level of the biosensor to reach optimal conditions and report
subtle modulations of endogenous kinases activity. The expres-
sion level of the reporter has to be sufficient to allow a reliable
detection of the light emitted by the BRET donor and accep-
tor. However the reporter expression level must not be excessive
to efficiently report the activity of endogenous kinases. We pre-
cisely defined the limits of REV expression to report ERK acti-
vation by EGF application in HEK cells. Similarly, in neurons,
we determined a cut-off for the minimal level of luminescence
emission required for an accurate BRET ratio measurement. In
order to exclude these non-reliable pixels displaying low lumi-
nescence value, we applied an exclusive threshold on the Em480
image before dividing Em535/Em480 pixel-by-pixel to obtain the
BRET image. The mean BRET values as well as the distribution
(Standard Deviation) of BRET obtained from a sensor express-
ing only the BRET donor entity was found to be homogenous
both in dendrites and soma. This result confirmed the accuracy
of our experimental conditions. Once again, in order to optimize
the number of REV molecules that would be phosphorylated to
report endogenous ERK activation, we chose neurons with the
weakest fluorescence, i.e., those in which the expression level of
REV was low. We further corroborate our BRET experiments by
WB experiments to reveal the phosphorylation of the reporter as
well as ERK auto-phosphorylation induced by ERK stimulation
in different conditions. The consistence of the results obtained
with BRET and WB, further validated our experimental condi-
tions. Nevertheless, it is important to mention that the expression
level of REV defined herein may not satisfy every kind of ERK
activation. In low ERK activation conditions, only a small amount
of REV would be phosphorylated by ERK activation, which would
prevent the optimal detection of ERK activity. This might be the
reason why REV failed to reliably report one of the weakest mod-
ulations of ERK activity we found by WB, the glycine-induced
modulation.
Rluc8-ERKsubstrate-Venus selectively reported ERK activity.
This was assessed by point mutation of the REV-phosphorylation
site, and by the use of ERK inhibitor, U0126. U0126 indeed put
emphasis on a basal ERK activity and was also effective in reversing
EGF- and PMA-induced BRET-increase. Intriguingly, this rever-
sion did not reach the BRET levels obtained with U1026 alone.
WB experiments confirmed that a pre-stimulation of ERK by
PMA led to ERK auto-phosphorylation and REV-phosphorylation
which were not totally abolished by a subsequent 50 min incu-
bation of U0126, Figure 2E. Thus U0126 has a higher potency
to decrease ERK substrate phosphorylation when applied alone.
The residual phosphorylation of ERK or REV following sequen-
tial application of PMA and U0126 might come from the fact
that once phosphorylated the REV sensor may be a poor sub-
strate for phosphatases and only a part of phosphorylated REV
would return to an inactivated state following U0126 incubation.
Moreover the dephosphorylation rate of REV may be different in
cells incubated only in U0126 compared to cells with high acti-
vation of ERK (EGF/PMA) since phosphatases activation could
be affected differently. Nor can one exclude a non-specific action
of U0126 and some phosphorylation of the ERK sensor, due not
only to ERK but to other kinases not inhibited by U0126. How-
ever, no BRET changes were recorded upon PMA application
in HEK293T cells transfected with the mutant REVT/A, argu-
ing in favor of the specificity of the biosensor to report ERK
phosphorylation.
This proof of principal study highlights several advantages of
REV to improve the detection of ERK activity. One obvious benefit
coming from the BRET-based sensor is the possibility to work on
living cells and report the kinetics of ERK activation in real time on
the same cell. FRET-reporters present the same advantage, but this
BRET biosensor displayed a higher sensitivity. Consequently, com-
pared to classical WB experiments, REV avoids the variability of
ERK activity measurements from different pools of cells over time.
Moreover, BRET imaging reported a variability of ERK activation
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status in a cell population. This cellular precision indeed extend
the need for biosensors such as REV, that could be used in real
time on the same living cell rather than pools of cells in which the
mean signal would not change over time. For example, the basal
ERK activation status could indeed have been a limiting factor to
see the NMDA effect (with a lower basal ERK activity, we may
have missed the NMDA-induced decrease of BRET). This com-
ment also applies to the sub-cellular location of the activation of
a signaling pathway. With BRET imaging we were able to high-
light subtleties in sub-cellular activation of ERK that we missed
with a more general approach such as WB experiments (see again
the NMDA-induced modulation of ERK reported by WB com-
pared to BRET, Figure 3). Even within sub-cellular compartments,
BRET imaging enables the characterization of the distribution of
BRET signals by measuring the standard deviation between pix-
els of the same area. For example, the high standard deviation
seen in dendrites of neurons expressing REV, even in basal con-
dition, indicates a spatial clusterization of the ERK activity along
dendrites. The cellular and sub-cellular precision thus increases
the sensitivity of the assay compared to global methods. Finally,
one fundamental property of REV is its high reproducibility. We
averaged the mean BRET intensity as well as the BRET distri-
bution (Standard Deviation) on several areas drawn in identical
compartment and stimulating conditions. Both averages displayed
small SEM, highlighting the reproducibility between similar areas,
and the consistence and accuracy of the results obtained with the
BRET sensor.
In this first study using REV we pointed out spatio-temporal
profiles of ERK activity induced by different stimuli, some of them
so far unrevealed by other technologies. Firstly, REV displayed a
basal BRET signal, which could be decreased by mutation of the
REV-phosphorylation site. This highlighted a basal ERK activity.
In neurons, this basal ERK activation was spatially clustered along
dendrites. One direct consequence of REV reporting basal activ-
ity of ERK is to allow the detection of decreases in ERK activity.
Secondly, in HEK cells, we found similar kinetics for cytoplasmic
and nuclear ERK activation, which confirms the data obtained
with FRET sensors by Harvey et al. (18). The exact molecular
mechanisms underlying ERK translocation to the nucleus are still
unknown and are the subject of interesting debate. This further
highlights the need for real-time sensors for ERK activity. Our
results suggest that regulation of ERK activity is similar in the
somatic cytoplasm and nucleus, possibly because of a rapid dif-
fusional exchange between the two compartments (30). Thirdly,
in neurons, we demonstrated that the strength, the location, and
the moment of ERK activation depends on the nature of the stim-
uli, highlighting that ERK is not simply switched on and off, but
rather that acute modulation of ERK will encode the nature of the
initial stimulus and specify the consequence of its activation. REV
is therefore well suited to address such an important biological
issue, not only in neurons but also in any other cell type.
Several experimental adaptations may improve the sensitivity
of this BRET-based biosensor. First we will increase the length
of the central flexible linker to increase the distance between the
donor and acceptor entities in the basal (non-phosphorylated)
condition. This should decrease the basal BRET signal still detected
with REV in presence of U0126 (ERK inhibitor), or with the
mutant of REVT/A that cannot be phosphorylated (REVT/A).
Accordingly, by decreasing basal BRET we expect a larger win-
dow for BRET modulations induced by ERK activation, which
could help in reporting subtle variations. Second, the use of BRET
compatible entities for the third generation of BRET [BRET3, with
Rluc8 as donor and mOrange as acceptor (31)] should also increase
the sensitivity of this assay. Indeed, the improved spectral resolu-
tion between Rluc8 and mOrange compared to Rluc8 and Venus
will minimize the bleed-through of the donor fluorescence into
the acceptor detection channel, decreasing the background signal
and therefore increasing the sensitivity of BRET measurements.
Accordingly, we replaced Venus by mOrange in the BRET-based
sensor to obtain REO (Rlu8-ERKsubstrat-mOrange). Ongoing
experiments are testing this reporter, which will further present
the advantage to be compatible with BRET1-based reporters of
other signaling pathways. Another way to improve this sensor
could be provided with a higher luminescence signal by pixel
without increasing the concentration of biosensor per cell, using
a new smaller and brighter luciferase called Nanoluc (Promega).
Finally, because the level of expression of the BRET-based sen-
sor is a limiting factor to accurately report ERK activity, we wish
to control the expression of the biosensor by endogenous pro-
moter in order to be in harmony with the expression levels of ERK
targets.
To conclude, this efficient ERK sensor has to be added to the
library of BRET-based sensors so far generated (32) and will
help understanding integrated signaling dynamics in time and
space (33).
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APPENDIX
FIGURE A1 | (A) Fluorescence lifetime images of a HEK293 cell expressing
cytosolic EKAR before and after (8 min) addition of EGF. (B) REV-
fluorescence (GFP) and ERK immunostaining (Anti-ERK) in HEK293 cells
transfected with plasmids coding for cytosolic and nuclear REV constructs.
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